21 CFR 524.1200b
§ 524.1200b Kanamycin ophthalmic solution.
United States · 21 CFR — Food and Drugs · Status: effective
Cite this
- Citation
- 21 CFR 524.1200b, § 524.1200b Kanamycin ophthalmic solution, United States, version 1 as recorded 2026-07-09, yourstate.us, https://yourstate.us/provision/87619
- Permanent ID
ys:prov:87619@1- SHA-256
13942785b8390784e5ae22ba7322b8da8b546bdc5333d0c9c5989b7a0ec49bf8
The hash is SHA-256 of this version's text, with every run of whitespace collapsed to a single space and the ends trimmed. The ID always leads back here, and checking it says whether the text you cited is still the current version.
Full text
(a) Specifications. Each milliliter of solution contains 10 milligrams kanamycin activity as kanamycin sulfate.
(b) Sponsor. See No. 054771 in § 510.600(c) of this chapter.
(c) Conditions of use in dogs—(1) Amount. Instill a few drops into the affected eye every 3 hours or more frequently if deemed advisable. Administer as frequently as possible for the first 48 hours, after which the frequency of applications may be decreased. Treatment should be continued for at least 48 hours after the eye appears normal.
(2) Indications for use. For the treatment of various eye infections (conjunctivitis, blepharitis, dacryocystitis, keratitis, and corneal ulcerations) due to bacteria sensitive to kanamycin. For prophylaxis in traumatic conditions, removal of foreign bodies, and intraocular surgery.
(3) Limitations. Federal law restricts this drug to use by or on the order of a licensed veterinarian.
Legislative history
This is a federal regulation, adopted through agency rulemaking under the Administrative Procedure Act — not enacted by a recorded vote of Congress.